BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36517035)

  • 1. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
    Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK; Shin SR
    Metab Syndr Relat Disord; 2024 Jun; 22(5):402-409. PubMed ID: 38574322
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population.
    Takahashi S; Tanaka M; Higashiura Y; Mori K; Hanawa N; Ohnishi H; Furuhashi M
    Endocr J; 2022 Apr; 69(4):463-471. PubMed ID: 34803123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
    Kilonzo SB; Kamala E; Jaka H; Ngoya P
    BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H; Han Y; Cao C; He Y
    J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
    Wang R; Dai L; Zhong Y; Xie G
    Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China.
    Xie F; Pei Y; Zhou Q; Cao D; Wang Y
    Lipids Health Dis; 2021 Oct; 20(1):132. PubMed ID: 34629056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.
    Kim AH; Son DH; Lee YJ
    Front Endocrinol (Lausanne); 2023; 14():1308265. PubMed ID: 38317718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
    Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride Glucose-Waist Circumference (TyG-WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease.
    Song S; Son DH; Baik SJ; Cho WJ; Lee YJ
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
    Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
    Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.
    Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W
    Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.